Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

A. Pardanani, R. R. Laborde, T. L. Lasho, C. Finke, K. Begna, A. Al-Kali, W. J. Hogan, M. R. Litzow, A. Leontovich, M. Kowalski, A. Tefferi

Research output: Contribution to journalArticlepeer-review

168 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences